Uncategorized

Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private […]

Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA

Podcast: Play in new window | Download (Duration: 35:36 — 81.5MB)

Subscribe: Apple Podcasts | Spotify | RSS

On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade

BIO (Biotech Innovation Organization) collected a survey in January of 2020 to better understand the current demographics of biopharma companies. Responses to their questions on representation indicate that the number of women decreases at higher levels.

Locust Walk is partnering with Applied Molecular Transport, Forma Therapeutics, and Goodwin for a live panel on Thursday, July 23rd from 1-2 pm EST entitled “The Unexpected IPO Boom for Biopharma in Q2.”

Locust Walk is partnering with Applied Molecular Transport, Forma Therapeutics, and Goodwin for a live panel on Thursday, July 23rd from 1-2 pm EST entitled “The Unexpected IPO Boom for Biopharma in Q2.”

Locust Walk is partnering with Santen Pharmaceutical Co., Ltd. CBC Group, and Goodwin to bring together a panel on Wednesday, July 1st, at 6 pm EST, entitled “Brave New World: Challenges from the East, Asia Biopharma, and Response to COVID-19.”

Danforth Advisors, Locust Walk, and Mintz joined on Thursday, June 11th from 2-3pm EST for the panel, “Accessing Capital in the Time of COVID: Challenges, Opportunities, and Best Practices.”

Thank you to all that joined us on Thursday, May 7th for our live panel discussion where we took a deep dive into biopharma deal marker’s best practices for strategic partnerships.